Guidant Lower after Court Setback
Boston Scientific (BSX ) says a U.S. appeals court denied requests by Cook Inc. and Guidant (GDT ) for a stay of injunction in their paclitaxel-coated stent dispute with Boston Scientific. Guidant shares fell on the news while Boston Scientific traded higher. CIBC World reiterated its sector underperform rating on Guidant.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.